Breaking News

Scenic Biotech enters into genetic modifier collaboration with Genentech

Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease ...

DCprime and Glycotope to advance cancer vaccination and therapeutic antibody platforms

DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage oncology/immuno- ...

Thermo Fisher collaborates with AstraZeneca and academics

The collaborations are part of Thermo Fisher's development of solutions for unmet needs in clinical biomarker discovery

Derisking and accelerating oral peptide delivery via computational drug development tools

The drug development pipeline increasingly comprises complex molecules, both large and small, that exhibit low ...

Paradigm4 launches app for large-scale data analysis

The app enables users to assess biological hypotheses for target evaluation, disease progression, and precision medicine

Asymchem and Snapdragon enter global partnership

The investment partnership has provided funding for Snapdragon to complete its expansion plan to build cGMP drug ...

Delivering success for inhaled drug development programmes

No two inhaled drug development programmes will have exactly the same characteristics or drivers; so, to ensure the ...

University of Oxford resumes vaccine trial

In large trials such as this, the researchers have said, it's expected that some participants will become unwell

Vectura partners with Monash University on inhaled oxytocin

The inhalation formula will be used instead of the current injection method

Optimising gene therapy for now and the future

With multiple gene therapies currently approved for use in the US, dozens in pivotal trials and hundreds more in ...

Accelerating vaccine development with AI

Despite the tremendous advances in medical science in recent decades, there is still so much about the human body that ...

Reducing time-to-market with innovative approaches to analytical services

The way in which drug developers approach analytical chemistry can be crucial in terms of driving efficiencies in ...

CombiGene and Cobra sign agreement for GMP plasmid production

The agreement is part of preparations for GMP production of material for the first clinical study of CG01

Evonetix and Analog Devices collaborate on DNA synthesis platform

The two companies began working together in January 2019